Phase 2 RCT: Once-weekly cagrilintide is effective for weight management in people with overweight and obesity.
17 Nov, 2021 | 08:23h | UTCOnce-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial – The Lancet (link to abstract – $ for full-text)